{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:16:42Z","timestamp":1788401802844,"version":"build-2803163510"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1097\/qai.0b013e3181b7354c","type":"journal-article","created":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T03:16:22Z","timestamp":1256094982000},"page":"371-381","source":"Crossref","is-referenced-by-count":31,"title":["A Randomized, Placebo-Controlled, Dose-Escalation Study to Determine the Safety, Tolerability, and Immunogenicity of an HPV-16 Therapeutic Vaccine in HIV-Positive Participants With Oncogenic HPV Infection of the Anus"],"prefix":"10.1097","volume":"52","author":[{"given":"Jonathan S","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Barnden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beng","family":"Eu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charmaine","family":"Gittleson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210131","first-page":"283","article-title":"Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem. AIDS (London, England).","volume":"8","author":"Palefsky","year":"1994","journal-title":""},{"key":"R2-11-20210131","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/oxfordjournals.aje.a117073","article-title":"Changing patterns of anal cancer incidence in the United States, 1940-1989.","volume":"139","author":"Melbye","year":"1994","journal-title":"Am J Epidemiol"},{"key":"R3-11-20210131","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.bjc.6603175","article-title":"Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975-2002.","volume":"95","author":"Brewster","year":"2006","journal-title":"Br J Cancer"},{"key":"R4-11-20210131","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/sti.2007.027250","article-title":"Abnormal anal cytology in high-risk human papilloma virus infection in HIV-infected Australians.","volume":"84","author":"Anderson","year":"2008","journal-title":"Sex Transm Infect"},{"key":"R6-11-20210131","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/01.qco.0000199019.50451.a8","article-title":"Human papillomavirus and anal intraepithelial neoplasia.","volume":"19","author":"Fox","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"R7-11-20210131","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(86)90168-6","article-title":"Association between anorectal dysplasia, human papillomavirus, and human immunodeficiency virus infection in homosexual men.","volume":"2","author":"Frazer","year":"1986","journal-title":"Lancet"},{"key":"R8-11-20210131","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/BF02234568","article-title":"High prevalence of anal squamous intraepithelial lesions and squamous-cell carcinoma in men who have sex with men as seen in a surgical practice.","volume":"44","author":"Goldstone","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"R9-11-20210131","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1071\/SH03019","article-title":"Is screening for anal cancer warranted in homosexual men?","volume":"1","author":"Anderson","year":"2004","journal-title":"Sex Health"},{"key":"R10-11-20210131","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/505219","article-title":"Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review.","volume":"43","author":"Chiao","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R11-11-20210131","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/344057","article-title":"Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus.","volume":"35","author":"Chin-Hong","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R12-11-20210131","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1007\/s10350-004-0889-0","article-title":"Infrared coagulator?: a useful tool for treating anal squamous intraepithelial lesions.","volume":"48","author":"Goldstone","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"R15-11-20210131","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1525-1381.1999.99723.x","article-title":"Papillomaviruses in human cancers.","volume":"111","author":"zur Hausen","year":"1999","journal-title":"Proc Assoc Am Physicians"},{"key":"R16-11-20210131","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1600-065X.1999.tb01288.x","article-title":"Potential strategies utilised by papillomavirus to evade host immunity.","volume":"168","author":"Frazer","year":"1999","journal-title":"Immunol Rev"},{"key":"R17-11-20210131","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1158\/0008-5472.CAN-04-0831","article-title":"Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-Cell immunity against early antigens E2 and E6.","volume":"64","author":"de Jong","year":"2004","journal-title":"Cancer Res"},{"key":"R18-11-20210131","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/S0264-410X(00)00497-7","article-title":"Immune responses to ISCOM formulations in animal and primate models.","volume":"19","author":"Sjolander","year":"2001","journal-title":"Vaccine"},{"key":"R19-11-20210131","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1016\/j.vaccine.2004.03.026","article-title":"ISCOMATRIX? adjuvant: an adjuvant suitable for use in anticancer vaccines.","volume":"22","author":"Stewart","year":"2004","journal-title":"Vaccine"},{"key":"R20-11-20210131","first-page":"745","article-title":"The potential of human papillomavirus vaccines. N Engl J Med. 2006 Mar 16;354:1109-1112.","volume":"355","author":"Steinbrook","year":"2006","journal-title":"Erratum in N Engl J Med"},{"key":"R21-11-20210131","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/01.aids.0000226955.02719.26","article-title":"A trial of SGN-00101 (HspE7) to treat high-grade anal intraepithelial neoplasia in HIV-positive individuals.","volume":"20","author":"Palefsky","year":"2006","journal-title":"AIDS"},{"key":"R22-11-20210131","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/ijgc-00009577-200605000-00020","article-title":"Prime-boost vaccination strategy in women with high-grade, noncervical anogenital intraepithelial neoplasia: clinical results from a multicenter phase II trial.","volume":"16","author":"Fiander","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"R23-11-20210131","doi-asserted-by":"crossref","first-page":"11120","DOI":"10.1158\/0008-5472.CAN-06-2560","article-title":"Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.","volume":"66","author":"Gambhira","year":"2006","journal-title":"Cancer Res"},{"key":"R24-11-20210131","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.vaccine.2004.05.013","article-title":"Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia.","volume":"23","author":"Frazer","year":"2004","journal-title":"Vaccine"},{"key":"R25-11-20210131","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1586\/14760584.6.5.761","article-title":"ISCOMATRIX adjuvant for prophylactic and therapeutic vaccines.","volume":"6","author":"Drane","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"R26-11-20210131","first-page":"343","article-title":"Design of a candidate recombinant therapeutic vaccine for cervical cancer.","volume":"1","author":"Edwards","year":"1998","journal-title":"Recent Res Devel Biotech Bioeng"},{"key":"R27-11-20210131","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 bethesda system: terminology for reporting results of cervical cytology.","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"R28-11-20210131","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.vaccine.2004.05.013","article-title":"Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX? adjuvant in women with cervical intraepithelial neoplasia.","volume":"23","author":"Frazer","year":"2004","journal-title":"Vaccine"},{"key":"R29-11-20210131","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11904-007-0016-7","article-title":"An overview of vaccinations in HIV.","volume":"4","author":"Overton","year":"2007","journal-title":"Curr HIV\/AIDS Rep"},{"key":"R30-11-20210131","first-page":"173","article-title":"Immunizations in HIV-infected adults.","volume":"9","author":"Rivas","year":"2007","journal-title":"AIDS Rev"},{"key":"R31-11-20210131","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00002030-200001070-00002","article-title":"Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group.","volume":"14","author":"Valdez","year":"2000","journal-title":"AIDS"},{"key":"R32-11-20210131","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/01.aids.0000186815.99993.55","article-title":"Response to hepatitis A vaccine in HIV patients in the HAART era.","volume":"19","author":"Rimland","year":"2005","journal-title":"AIDS"},{"key":"R33-11-20210131","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1159\/000325866","article-title":"Increased sensitivity of anal cytology in evaluation of internal compared with external lesions.","volume":"51","author":"Garcia","year":"2007","journal-title":"Acta cytol"},{"key":"R34-11-20210131","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/01.qco.0000199019.50451.a8","article-title":"Human papillomavirus and anal intraepithelial neoplasia.","volume":"19","author":"Fox","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"R35-11-20210131","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/sti.2003.008318","article-title":"The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic.","volume":"81","author":"Fox","year":"2005","journal-title":"Sex Transm Infect"},{"key":"R36-11-20210131","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1258\/095646203765371321","article-title":"Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.","volume":"14","author":"Branca","year":"2003","journal-title":"Int J STD AIDS"},{"key":"R37-11-20210131","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0090-8258(03)00268-3","article-title":"Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization.","volume":"90","author":"Costa","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R38-11-20210131","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/01.aids.0000181012.62385.4a","article-title":"Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men.","volume":"19","author":"Palefsky","year":"2005","journal-title":"AIDS"},{"key":"R39-11-20210131","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.OLQ.0000109515.75864.2B","article-title":"High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy.","volume":"31","author":"Piketty","year":"2004","journal-title":"Sex Transm Dis"},{"key":"R40-11-20210131","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/318071","article-title":"Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.","volume":"183","author":"Palefsky","year":"2001","journal-title":"J Infect Dis"},{"key":"R41-11-20210131","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00002030-200301240-00028","article-title":"Lack of response of anal intra-epithelial neoplasia to highly active antiretroviral therapy.","volume":"17","author":"Fox","year":"2003","journal-title":"AIDS"},{"key":"R42-11-20210131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"R43-11-20210131","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/514194","article-title":"Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men.","volume":"177","author":"Palefsky","year":"1998","journal-title":"J Infect Dis"},{"key":"R44-11-20210131","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/sti.2007.027250","article-title":"Abnormal anal cytology related to high-risk HPV infection in HIV-infected Australians.","volume":"84","author":"Anderson","year":"2008","journal-title":"Sex Transm Infect"},{"issue":"pt 11","key":"R45-11-20210131","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1099\/0022-1317-70-11-3099","article-title":"Human papillomavirus type 56: a new virus detected in cervical cancers.","volume":"70","author":"Lorincz","year":"1989","journal-title":"J Gen Virol"},{"key":"R46-11-20210131","first-page":"74","article-title":"Detection of high-risk HPV (16, 18, 33) in situ cancer of the cervix by PCR technique.","volume":"23","author":"Pete","year":"2002","journal-title":"Eur J Gynaecol Oncol"},{"key":"R47-11-20210131","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/jcp.44.5.406","article-title":"In situ evidence for HPV 16, 18, 33 integration in cervical squamous cell cancer in Britain and South Africa.","volume":"44","author":"Cooper","year":"1991","journal-title":"J Clin Pathol"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-200911010-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:04:25Z","timestamp":1786039465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-200911010-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181b7354c","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}